GLENMEDE TRUST CO NA
BankPosition in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 314949
PHILADELPHIA, PA
Position in VRTX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$6,319,398
+$3,815,203 QoQ
Shares Held
12,722
+126.9% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#433
of 1,735 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 11%
Shared 0%
None 89%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GLENMEDE TRUST CO NA holds $148,775,467 across 46 Biotechnology names. VRTX ranks #6 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
538,822 | $61,080,861 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
488,546 | $12,360,212 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
206,405 | $11,810,493 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
141,317 | $11,060,881 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,621 | $10,987,396 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
12,722 | $6,319,398 | |
| 7 | VCEL |
Vericel Corp
|
139,921 | $6,225,084 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
7,637 | $2,413,979 |
All Filings in VRTX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,319,398 | 12,722 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $2,504,195 | 5,608 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $2,420,488 | 5,339 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $2,295,622 | 4,735 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,943,027 | 4,825 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,903,572 | 4,093 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $62,254,452 | 132,818 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $56,465,207 | 135,081 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $70,837,921 | 174,096 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $67,598,220 | 194,393 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $69,938,944 | 198,741 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $62,650,723 | 198,847 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $55,071,212 | 190,703 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $46,246,197 | 159,723 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $44,402,213 | 157,572 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $42,009,644 | 160,975 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $3,062,761 | 13,947 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $2,773,814 | 15,292 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,580,661 | 12,799 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,397,643 | 6,504 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $15,507,920 | 65,617 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $995,685 | 3,659 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $902,573 | 3,109 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $598,444 | 2,515 | Shares | Defined | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||